Guangdong VTR Bio-Tech Co., Ltd. announced that it expects to receive CNY 1.09 billion in funding from Zhuhai Jindadi Investment Co., Ltd. and other investors
January 12, 2017
Share
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) announced a private placement of not more than 60,316,277 shares at no less than CNY 18 per share for gross proceeds of not more than CNY 1,085,693,000 on January 13, 2017. The transaction will include participation from not more than five investors, wherein Zhuhai Jindadi Investment Co., Ltd. will invest not less than 25% of the total proceeds. The shares subscribed by Zhuhai Jindadi Investment Co., Ltd. cannot be transferred within 36 months from the issuance closing date. The transaction has been approved in the 26th meeting of the 5th directorate, 27th session of the company’s 5th directorate held on March 27, 2017, 30th session of the company’s 5th directorate held on May 16, 2017, 37th session of the company’s 5th directorate held on August 28, 2017, company’s 2nd special shareholders’ meeting for 2017 held on April 12, 2017 and is subject to the approvals of the company’s shareholders and the China Securities Regulatory Commission.
Guangdong VTR Bio-Tech Co Ltd is a China-based company mainly engaged in biotechnology services. The Company is mainly engaged in the research and development, production, sales and service of bioenzyme preparations, biosynthetic products and nutrition and health products, and provides customers with overall biotechnology solutions. The bioenzyme preparations are used in many fields such as feed, food, energy, pharmaceuticals, textiles, papermaking, environmental protection, brewing, starch sugar, detergents and health products. The biosynthetic products include medicines, food, feed, cosmetics, medical devices, and others. The nutrition and health products are mainly animal nutrition and health products, including feed additives, plant extracts, and others.
Guangdong VTR Bio-Tech Co., Ltd. announced that it expects to receive CNY 1.09 billion in funding from Zhuhai Jindadi Investment Co., Ltd. and other investors